Modulation of cabozantinib efficacy by the prostate tumor microenvironment

The tumor microenvironment (TME) is increasingly recognized as the arbiter of metastatic progression and drug resistance in advanced prostate cancer (PCa). Cabozantinib is a potent tyrosine kinase inhibitor (TKI) with reported biological activity in the PCa epithelia, but failed to provide an overal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Tripathi, Manisha, Nandana, Srinivas, Billet, Sandrine, Cavassani, Karen A., Mishra, Rajeev, Chung, Leland W.K., Posadas, Edwin M., Bhowmick, Neil A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5675680/
https://ncbi.nlm.nih.gov/pubmed/29152128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21248
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi